Expression of CD9 and CD82 in papillary thyroid microcarcinoma and its prognostic significance
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Taeyoung | - |
dc.contributor.author | Kim, Yonhee | - |
dc.contributor.author | Kwon, Hyeong Ju | - |
dc.date.accessioned | 2021-08-11T11:23:39Z | - |
dc.date.available | 2021-08-11T11:23:39Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 0423-104X | - |
dc.identifier.issn | 2299-8306 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/5326 | - |
dc.description.abstract | Introduction: papillary thyroid microcarcinoma is a well-known malignant neoplasm with good prognosis. The known prognostic factors are patient's age, multifocality, and extra thyroidal extension. CD9 and CD82, members of the tetraspanin family, are expressed in numerous cancer cells and play many roles associated with the cellular process. Material and methods: we investigated the immunohistochemical expression of CD9 and CD82 in papillary thyroid microcarcinoma and analysed the clinicopathological and prognostic significance. For the retrospective analysis, we collected the cases of 553 PTMC patients who had undergone thyroidectomy. Results: The group with lymph node metastasis showed higher immunostaining intensity for CD9 than the group without metastasis (p = 0.002). In multivariate analysis, high CD9 intensity (OR = 1.58 in 3+, p= 0.0025) correlated with lymph node metastasis. Conclusion: We suggest CD9 as a predictive prognostic factor for lymph node metastasis in PTMC. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Polish Endocrinological Association | - |
dc.title | Expression of CD9 and CD82 in papillary thyroid microcarcinoma and its prognostic significance | - |
dc.type | Article | - |
dc.publisher.location | 폴란드 | - |
dc.identifier.doi | 10.5603/EP.a2019.0009 | - |
dc.identifier.wosid | 000474881900003 | - |
dc.identifier.bibliographicCitation | Endokrynologia Polska, v.70, no.3, pp 224 - 231 | - |
dc.citation.title | Endokrynologia Polska | - |
dc.citation.volume | 70 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 224 | - |
dc.citation.endPage | 231 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | EPIDERMAL-GROWTH-FACTOR | - |
dc.subject.keywordPlus | DOWN-REGULATION | - |
dc.subject.keywordPlus | CELL-MIGRATION | - |
dc.subject.keywordPlus | OVARIAN-CANCER | - |
dc.subject.keywordPlus | UP-REGULATION | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | KAI1/CD82 | - |
dc.subject.keywordPlus | KAI1 | - |
dc.subject.keywordPlus | MRP-1/CD9 | - |
dc.subject.keywordPlus | MEMBRANE | - |
dc.subject.keywordAuthor | CD9 | - |
dc.subject.keywordAuthor | CD82 | - |
dc.subject.keywordAuthor | prognosis | - |
dc.subject.keywordAuthor | papillary thyroid microcarcinoma | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.